Furthermore, immunohistochemistry showed that the expression levels of BCL‐2 and MCL‐1, two major cell apoptosis‐related molecules, were decreased by vandetanib in K562 tumor tissues (Fig. 5J). The gene discussed is BCL2; the disease is neoplasm.